Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 8, 2025Seminars in Respiratory and Critical Care Medicine

Autoimmune Pulmonary Alveolar Proteinosis (PAP)

View Full Paper
Ask AI
Bookmark
Share

Authors

SPSpyros A. PapirisMKMaria KallieriMZMaurizio Zompatori

Discussion

Loading...

Member takes

Overview

Observational analysis shows increased lung infections and respiratory failure in patients with aPAP, highlighting new therapeutic modalities to address underlying pathogenesis.

Key Points

  • Lung infections and pulmonary fibrosis escalate patient risk and morbidity in autoimmune pulmonary alveolar proteinosis.
  • Recent findings suggest inhaled-GM-CSF improves clinical outcomes compared to traditional treatments over time.
  • Assessment using diagnostic tools identifies the role of GM-CSF autoantibodies in pathogenesis of alveolar macrophages.
  • Pathogenetic mechanisms reveal surfactant accumulation as a critical factor in disease development and severity.

Cite This Study

Papiris et al. (2025) studied this question.

synapsesocial.com/papers/690e8b6ca5b062d7a4e733c7https://doi.org/10.1055/a-2737-7719
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Recent advances in the diagnosis and management of pulmonary alveolar proteinosis2025 · 4 citations
  2. 2Targeting autoimmune pulmonary alveolar proteinosis with GM-CSF: insights from clinical trials and emerging therapies2026
  3. 3Pulmonary alveolar proteinosis in Denmark: a retrospective cohort study2025
  4. 4Serial Anti-GM-CSF Autoantibody Levels Reflect Disease Activity in Hypersensitivity Pneumonitis with Autoimmune Pulmonary Alveolar Proteinosis: Case Report2025
  5. 5Pulmonary alveolar proteinosis with atypical clinical and bronchoscopic features2025 · 1 citations